On June 29, 2023, Century Therapeutics Inc announced that it had held its 2023 annual meeting of shareholders on June 27, 2023 and declared the voting results. As there has been no further engagement between Casdin Capital LLC and Century Therapeutics Inc, the campaign is considered to have been withdrawn.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -8.57% | -6.80% | -13.25% |
Apr. 12 | Piper Sandler Adjusts Price Target on Century Therapeutics to $9 From $10, Maintains Overweight Rating | MT |
Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.25% | 237M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IPSC Stock
- News Century Therapeutics, Inc.
- Declaration of Voting Results by Century Therapeutics